Meanwhile, our findings demonstrate that patients with PRL dysregulation present significantly larger breast lesions, with a positive correlation observed between PRL levels and lesion dimensions, reinforcing the pathophysiological link between hyperprolactinemia and disease severity. The gene discussed is PRL; the disease is hyperprolactinemia.